GLOBAL POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2027

GLOBAL POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2027

The global point of care diagnostic market is anticipated to grow at a CAGR of 9.28% between 2019 and 2027 to generate revenue of $57,482 million by 2027. The point of care (POC) tests denotes to the diagnostic processes, which are directed outside the laboratories. The important drivers that have been enhancing the growth of the global point of care diagnostic market are the growing prevalence of chronic and infectious diseases and the rise in the implementation of healthcare reforms.

GLOBAL POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2027

Global Point of Care Diagnostics Market by Mode of Prescription (Prescription Based Devices, Otc Based Devices) by End-user (Professional Diagnostic Centers, Research Laboratories, Home Care, Other End-user) by Product Type (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy and Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monitoring Kits, Urinalysis Testing Kits, Coagulation Monitoring Kits, Tumor/cancer Markers Testing Kits, Cholesterol Testing Trips, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits, Other Product) by Geography.

Request free sample

The global point of care diagnostic market is anticipated to grow at a CAGR of 9.28% between 2019 and 2027 to generate revenue of $57,482 million by 2027. The point of care (POC) tests denotes to the diagnostic processes, which are directed outside the laboratories. The point of care diagnostic market is primarily driven by the following factors:

  • Growing prevalence of chronic and infectious diseases
  • The rise in the implementation of healthcare reforms
  • Rising demand for decentralized chronic and infectious disease testing

The important drivers that have been enhancing the growth of the global point of care diagnostic market are the growing prevalence of chronic and infectious diseases and the rise in the implementation of healthcare reforms. Points of care diagnostic devices are widely used in the treatment of chronic and infectious diseases. For instance, the continuous development of strip technology, along with meter-type readers, is exemplified by the glucose meter used in the diagnosis of diabetes. The primary care initiatives that support the medical home transformation, indirectly ropes innovation in the healthcare landscape.

The point of care diagnostic product types are used extensively for various purposes. Glucose monitoring devices are used to measure the amount of glucose or sugar level in the bloodstream. Infectious diseases testing kits comprises of Hepatitis testing kit, HIV testing kits, Influenza testing kits, HAIs, STDs testing kits, Respiratory infections testing kits, and other infectious diseases testing kits. Pregnancy and fertility testing kits devices help to determine the exact day of ovulation and positive tests of pregnancy. Hematology testing kits are used in medical laboratories where they are employed for blood counting, detection of enzymes or proteins, and diagnosis of genetic disorders. Cardiometabolic monitoring kits provide timely cardiovascular and metabolic information at the point of care healthcare settings, which include hospitals, laboratories, and at home. Urinalysis testing devices are used to diagnose pathological changes in a patient’s urine. Cholesterol testing strips offer a convenient and effective way to test cholesterol level and provide the results in minutes. Fecal occult testing kits are employed to measure the presence of hidden (occult) blood in the stool.

Stringent regulation and insufficient reimbursement policies are the major factors hindering the point of care diagnostic market. The new POC product that is introduced in the market has to go through the regulatory approval process and meet the requirements of medical devices. The product approval process is very stringent and lengthy. Inadequate reimbursements policies and limited insurance coverage pose a major challenge for the affordability of these devices

The global point of care diagnostic market segments includes mode of prescription, end-user and product type.

Mode of prescription is segmented into:

  • Prescription Based Devices
  • OTC Based Devices

End-user is segmented into:

  • Professional diagnostic centers
    • Hospitals/critical care centers
    • Outpatient healthcare settings
    • Ambulatory care settings
  • Research laboratories
  • Home care
  • Other End-user

Product type is segmented into:

  • Glucose monitoring kits
  • Cardiometabolic monitoring kits
    • Hba1c testing kits
    • Cardiac markers kits
    • Electrolytes and metabolites testing kits
  • Infectious diseases kits
    • STD testing kits
    • Respiratory infections kits
    • HIV testing kits
    • Hepatitis testing kits
    • Influenza testing kits
    • HAIS
    • Other infectious diseases testing kits
  • Pregnancy and fertility kits
    • Fertility kits
    • Pregnancy kits
  • Hematology kits
  • Drugs of abuse kits
  • Cancer/ Tumor markers testing kits
  • Fecal occult testing kits
  • Urinalysis testing kits
  • Coagulation monitoring kits
  • Cholesterol testing trips
  • Other product

This report covers the present market conditions and the growth prospects of the global point of care diagnostic market for 2019-2027 and considered the revenue generated through the sales of point of care diagnostic for mode of prescription, end-user as well as product type to calculate the market size by considering 2018 as the base year.

Geographically, the global Point of care diagnostic market has been segmented on the basis of four major regions, which include:

The point of care diagnostic market in North America is expected to hold the largest share by 2027 due to the possibilities of the rising incidence and prevalence of diseases such as diabetes and cardiac disorders accompanied by the rise in the elderly population. Increased awareness about innovative and advanced applications of POC diagnostic devices and well-established healthcare infrastructure also supports the growth of the point of care diagnostics market in North America. On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the Point of care diagnostic market. Factors such as limited resource usability coupled with increasing prevalence rates, and technological advancements, are the major drivers in Asia Pacific segment of point of care testing market is expected to witness the fastest growth over the forecast period.

The Point of care diagnostic Market is segmented on End-user which is sub-divided into research laboratories, professional diagnostic centres, home care and other end-user and also segmented on the basis of mode of prescription which is sub-divided into prescription based devices and OTC based devices. In professional diagnostic centres, the POC diagnostic procedures are performed in various departments that include inpatient department (IPD) and outpatient department (OPD), hospital wards, cardiac centres, and others. The research laboratories use POC diagnostic devices in the research process, which includes clinical trials of various new drugs and medical devices. The home care End-user of POC diagnostic devices increases steadily due to an increase in awareness about personalized healthcare and the importance of continuous monitoring in the management of some diseases like diabetes. Prescription based devices are mostly preferred due to the ensured safety and their effective use in the treatment of various diseases. Increase in demand for the OTC glucose monitoring devices for the management of diabetes is the major factor to drive the growth of this market.

The major market players of the global point of care diagnostic market are:

  • Abbott
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Cardinal Health Inc.

Company Profiles covers the analysis of important players. Abbott Diagnostic is a US-based medical equipment manufacturer company, headquartered in Illinois. Abbot diagnostic, a manufacturer of in vitro diagnostics, offers a range of medical instruments, tests, and systems for clinics and hospitals. Cardinal Health has a diverse portfolio of pharmaceutical and medical-surgical products. Its pharmaceutical products include retail products and mail-order facilities at hospitals and physician offices. The surgical product portfolio comprises products for ambulatory care, clinical laboratories, hospitals, and physicians.

Key Findings of the global point of care diagnostic market:

  • Infectious disease testing kit is the fastest growing product type during the forecast period.
  • Professional diagnostic centers are the major end-user in point of care market.
  • Prescription based devices are the frequently used mode of prescription.
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • INFECTIOUS DISEASE TESTING KIT IS THE FASTEST GROWING PRODUCT TYPE DURING THE FORECAST PERIOD
      • PROFESSIONAL DIAGNOSTIC CENTERS ARE THE MAJOR END-USER IN POINT OF CARE MARKET
      • PRESCRIPTION BASED DEVICES ARE THE FREQUENTLY USED MODE OF PRESCRIPTION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • GROWING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
      • RISE IN THE IMPLEMENTATION OF HEALTHCARE REFORMS
      • RISING DEMAND FOR DECENTRALIZED CHRONIC AND INFECTIOUS DISEASE TESTING
    • MARKET RESTRAINTS
      • STRINGENT REGULATION
      • INSUFFICIENT REIMBURSEMENT POLICIES
    • MARKET OPPORTUNITIES
      • REDUCTION IN THE HEALTHCARE COST FACILITATES
      • RISING INCIDENCES AND PREVALENCE RATES OF VARIOUS INFECTIOUS DISEASES
      • GROWING NUMBER OF SMARTPHONE EMPOWERS PATIENTS TO MONITOR THEIR CLINICAL CONDITION ONLINE
    • MARKET CHALLENGES
      • CHALLENGES RELATED TO THE EXECUTION OF HIGHLY SENSITIVE DEVICES
      • VARIATION IN TEST RESULTS
      • DIFFICULTIES ASSOCIATED IN DATA MANAGEMENT
  1. MARKET BY MODE OF PRESCRIPTION
    • PRESCRIPTION BASED DEVICES
    • OTC BASED DEVICES
  2. MARKET BY END-USER
    • PROFESSIONAL DIAGNOSTIC CENTERS
      • HOSPITALS/CRITICAL CARE CENTERS
      • OUTPATIENT HEALTHCARE SETTINGS
      • AMBULATORY CARE SETTINGS
    • RESEARCH LABORATORIES
    • HOME CARE
    • OTHER END-USER
  3. MARKET BY PRODUCT TYPE
    • GLUCOSE MONITORING KITS
    • INFECTIOUS DISEASES TESTING KITS
      • HEPATITIS TESTING KITS
      • HIV TESTING KITS
      • RESPIRATORY INFECTIONS TESTING KITS
      • INFLUENZA TESTING KITS
      • HAIS
      • STD TESTING KITS
      • OTHER INFECTIOUS DISEASES TESTING KITS
    • PREGNANCY AND FERTILITY TESTING KITS
      • PREGNANCY TESTING KITS
      • FERTILITY TESTING KITS
    • HEMATOLOGY TESTING KITS
    • CARDIOMETABOLIC MONITORING KITS
      • CARDIAC MARKERS KITS
      • HBA1C TESTING KITS
      • ELECTROLYTES AND METABOLITES TESTING KITS
    • URINALYSIS TESTING KITS
    • COAGULATION MONITORING KITS
    • TUMOR/CANCER MARKERS TESTING KITS
    • CHOLESTEROL TESTING TRIPS
    • DRUGS OF ABUSE TESTING KITS
    • FECAL OCCULT TESTING KITS
    • OTHER PRODUCT
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL ANALYSIS
    • REGULATORY FRAMEWORK
    • PATENT ANALYSIS
    • ETYMOLOGY OF POINT OF CARE MARKET
    • OPPORTUNITY MATRIX
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPANY PROFILES
    • ABBOTT
    • BECTON DICKINSON AND COMPANY
    • BIOMÉRIEUX SA
    • BIO-RAD LABORATORIES, INC.
    • CARDINAL HEALTH INC.
    • CHEMBIO DIAGNOST ICS SYSTEMS, INC.
    • DANAHER CORPORATION
    • GENE POC
    • HOFFMANN-LA ROCHE LTD.
    • ORTHO CLINICAL DIAGNOSTICS
    • QUEST DIAGNOSTICS INC.
    • SIEMENS HEALTHINEERS
    • SIGHT DIAGNOSTICS LTD.
    • THERMO FISHER SCIENTIFIC INC.
    • TRINITY BIOTECH
    • TRIVITRON HEALTHCARE

LIST OF TABLE

TABLE 1        GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY MODE OF PRESCRIPTION 2019-2027 ($ MILLION)

TABLE 3        GLOBAL PRESCRIPTION BASED DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 4        GLOBAL OTC BASED DEVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 5        GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 6        GLOBAL PROFESSIONAL DIAGNOSTIC CENTERS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 7        GLOBAL PROFESSIONAL DIAGNOSTIC CENTERS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 8        GLOBAL RESEARCH LABORATORIES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 9        GLOBAL HOME CARE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 10      GLOBAL OTHER END-USER MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 11      GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY PRODUCT TYPE 2019-2027 ($ MILLION)

TABLE 12      GLOBAL GLUCOSE MONITORING KITS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13      GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 14      GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 15      GLOBAL PREGNANCY AND FERTILITY TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 16      GLOBAL PREGNANCY AND FERTILITY TESTING KITS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 17      GLOBAL HEMATOLOGY TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 18      GLOBAL CARDIOMETABOLIC MONITORING KITS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19      GLOBAL CARDIOMETABOLIC MONITORING KITS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 20      GLOBAL URINALYSIS TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 21      GLOBAL COAGULATION MONITORING KITS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 22      GLOBAL TUMOR/CANCER MARKERS TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 23      GLOBAL CHOLESTEROL TESTING TRIPS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 24      GLOBAL DRUGS OF ABUSE TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 25      GLOBAL FECAL OCCULT TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 26      GLOBAL OTHER PRODUCT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 27      GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 28      NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 29      EUROPE POINT OF CARE DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 30      ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 31      REST OF WORLD POINT OF CARE DIAGNOSTICS MARKET BY REGION 2019-2027 ($ MILLION)

LIST OF FIGURE

FIGURE 1      GLOBAL POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 2      GLOBAL POINT OF CARE DIAGNOSTICS MARKET SHARE BY MODE OF PRESCRIPTION 2018 & 2027 (%)

FIGURE 3      GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY PRESCRIPTION BASED DEVICES 2019-2027 ($ MILLION)

FIGURE 4      GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY OTC BASED DEVICES 2019-2027 ($ MILLION)

FIGURE 5      GLOBAL POINT OF CARE DIAGNOSTICS MARKET SHARE BY END-USER 2018 & 2027 (%)

FIGURE 6      GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY PROFESSIONAL DIAGNOSTIC CENTERS 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL PROFESSIONAL DIAGNOSTIC CENTERS MARKET BY HOSPITALS/CRITICAL CARE CENTERS 2019-2027 ($ MILLION)

FIGURE 8      GLOBAL PROFESSIONAL DIAGNOSTIC CENTERS MARKET BY OUTPATIENT HEALTHCARE SETTINGS 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL PROFESSIONAL DIAGNOSTIC CENTERS MARKET BY AMBULATORY CARE SETTINGS 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY RESEARCH LABORATORIES 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY HOME CARE 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY OTHER END-USER 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL POINT OF CARE DIAGNOSTICS MARKET SHARE BY PRODUCT TYPE 2018 & 2027 (%)

FIGURE 14   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY GLUCOSE MONITORING KITS 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY INFECTIOUS DISEASES TESTING KITS 2019-2027 ($ MILLION)

FIGURE  16  GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY HEPATITIS TESTING KITS  2019-2027 ($ MILLION)

FIGURE  17  GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY HIV TESTING KITS  2019-2027 ($ MILLION)

FIGURE 18   GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY RESPIRATORY INFECTIONS TESTING KITS 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY INFLUENZA TESTING KITS  2019-2027 ($ MILLION)

FIGURE 20   GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY HAIS 2019-2027 ($ MILLION)

FIGURE 21   GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY STDS TESTING KITS 2019-2027 ($ MILLION)

FIGURE 22   GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY OTHER INFECTIOUS DISEASES TESTING KITS 2019-2027 ($ MILLION)

FIGURE 23   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY PREGNANCY AND FERTILITY TESTING KITS 2019-2027 ($ MILLION)

FIGURE 24   GLOBAL PREGNANCY AND FERTILITY TESTING KITS MARKET BY PREGNANCY TESTING KITS 2019-2027 ($ MILLION)

FIGURE 25   GLOBAL PREGNANCY AND FERTILITY TESTING KITS MARKET BY FERTILITY TESTING KITS 2019-2027 ($ MILLION)

FIGURE 26   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY HEMATOLOGY TESTING KITS 2019-2027 ($ MILLION)

FIGURE 27   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY CARDIOMETABOLIC MONITORING KITS 2019-2027 ($ MILLION)

FIGURE 28   GLOBAL CARDIOMETABOLIC MONITORING KITS MARKET BY CARDIAC MARKERS KITS 2019-2027 ($ MILLION)

FIGURE 29   GLOBAL CARDIOMETABOLIC MONITORING KITS MARKET BY HBA1C TESTING KITS 2019-2027 ($ MILLION)

FIGURE 30   GLOBAL CARDIOMETABOLIC MONITORING KITS MARKET BY ELECTROLYTES AND METABOLITES TESTING KITS 2019-2027 ($ MILLION)

FIGURE 31   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY URINALYSIS TESTING KITS 2019-2027 ($ MILLION)

FIGURE 32   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY COAGULATION MONITORING KITS 2019-2027 ($ MILLION)

FIGURE 33   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY TUMOR/CANCER MARKERS TESTING KITS 2019-2027 ($ MILLION)

FIGURE 34   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY CHOLESTEROL TESTING TRIPS 2019-2027 ($ MILLION)

FIGURE 35   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY DRUGS OF ABUSE TESTING KITS 2019-2027 ($ MILLION)

FIGURE 36   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY FECAL OCCULT TESTING KITS 2019-2027 ($ MILLION)

FIGURE 37   GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY OTHER PRODUCT 2019-2027 ($ MILLION)

FIGURE 38   PORTER’S FIVE FORCE MODEL

FIGURE 39   GLOBAL POINT OF CARE DIAGNOSTICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 40   THE UNITED STATES POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 41   CANADA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 42   GERMANY POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 43   FRANCE POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 44   THE UNITED KINGDOM POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 45   ITALY POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 46   SPAIN POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 47   REST OF EUROPE POINT OF CARE DIAGNOSTICS S MARKET 2019-2027 ($ MILLION)

FIGURE 48   JAPAN POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 49   CHINA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 50   INDIA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 51   AUSTRALIA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 52   SOUTH KOREA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 53   REST OF ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 54   LATIN AMERICA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 55   MIDDLE EAST AND AFRICA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

  1. MARKET BY MODE OF PRESCRIPTION
    • PRESCRIPTION BASED DEVICES
    • OTC BASED DEVICES
  2. MARKET BY END-USER
    • PROFESSIONAL DIAGNOSTIC CENTERS
      • HOSPITALS/CRITICAL CARE CENTERS
      • OUTPATIENT HEALTHCARE SETTINGS
      • AMBULATORY CARE SETTINGS
    • RESEARCH LABORATORIES
    • HOME CARE
    • OTHER END-USER
  3. MARKET BY PRODUCT TYPE
    • GLUCOSE MONITORING KITS
    • INFECTIOUS DISEASES TESTING KITS
      • HEPATITIS TESTING KITS
      • HIV TESTING KITS
      • RESPIRATORY INFECTIONS TESTING KITS
      • INFLUENZA TESTING KITS
      • HAIS
      • STD TESTING KITS
      • OTHER INFECTIOUS DISEASES TESTING KITS
    • PREGNANCY AND FERTILITY TESTING KITS
      • PREGNANCY TESTING KITS
      • FERTILITY TESTING KITS
    • HEMATOLOGY TESTING KITS
    • CARDIOMETABOLIC MONITORING KITS
      • CARDIAC MARKERS KITS
      • HBA1C TESTING KITS
      • ELECTROLYTES AND METABOLITES TESTING KITS
    • URINALYSIS TESTING KITS
    • COAGULATION MONITORING KITS
    • TUMOR/CANCER MARKERS TESTING KITS
    • CHOLESTEROL TESTING TRIPS
    • DRUGS OF ABUSE TESTING KITS
    • FECAL OCCULT TESTING KITS
    • OTHER PRODUCT
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now